1.
AJAIC-Alexandria Journal of Anaesthesia and Intensive Care. 2003; 6 (2): 60-64
em Inglês
| IMEMR
| ID: emr-61336
2.
New Egyptian Journal of Medicine [The]. 2000; 23 (6): 269-280
em Inglês
| IMEMR
| ID: emr-54885
RESUMO
This study was carried out on IDDM patients classified into group I and group II according to the absence or presence of impairment of hearing, respectively. Impairment of hearing was determined by using pure tone audiometry [PTA], distortion product otoacoustic emissions [DPOAE] and brain stem evoked response audiometer [ABR]. The selection of cases, the idea of the study, interpretation of data and comments were presented. It was concluded that soluble VCAM- 1 and s- ICAM-1 were positively associated with the risk for hearing loss in IDDM patients. Soluble VCAM-1 and sICAM-1 may be useful indicators of hearing loss in IDDM patients
Assuntos
Humanos , Masculino , Feminino , Diabetes Mellitus Tipo 1/imunologia , Molécula 1 de Adesão de Célula Vascular , Molécula 1 de Adesão Intercelular , Surdez , Distúrbios da Fala
3.
Zagazig University Medical Journal. 1999; 5 (7): 233-54
em Inglês
| IMEMR
| ID: emr-53128
Assuntos
Humanos , Feminino , Tiroxina , Sinais e Sintomas , Colesterol , Triglicerídeos , Lipoproteínas LDL , Lipoproteínas HDL , Resultado do Tratamento , Estudos Prospectivos
4.
Zagazig University Medical Journal. 1999; 5 (7): 293-312
em Inglês
| IMEMR
| ID: emr-53131